Area of research
Immunology · Oncology
Research interest
Research interests include Biology, T-cell receptor, CD8, Adoptive cell transfer, Antigen, and T cell.
First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A*02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid Neoplasms
Toll‐like receptor 7/8‐matured RNA‐transduced dendritic cells as post‐remission therapy in acute myeloid leukaemia: results of a phase I trial
Chimeric PD-1:28 Receptor Upgrades Low-Avidity T cells and Restores Effector Function of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy
Unbiased Identification of T-Cell Receptors Targeting Immunodominant Peptide–MHC Complexes for T-Cell Receptor Immunotherapy
Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice
T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice
Codon Optimization of the Human Papillomavirus E7 Oncogene Induces a CD8+ T Cell Response to a Cryptic Epitope Not Harbored by Wild-Type E7
Misinitiation of intrathymic <i>MART‐1</i> transcription and biased TCR usage explain the high frequency of MART‐1‐specific T cells
TCR-transgenic lymphocytes specific for HMMR/Rhamm limit tumor outgrowth in vivo
Human Antitumor CD8+ T Cells Producing Th1 Polycytokines Show Superior Antigen Sensitivity and Tumor Recognition